Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Constipation 6 Intestinal Diseases 5 Pain 3 Neoplasms 3 Urinary Bladder Neoplasms 2 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Opioid-Induced Constipation 1 Ileus 1 Fallopian Tube Neoplasms 1 Cancer Pain 1

Interventions

Paclitaxel 24 Hyperthermic Intraperitoneal Chemotherapy 24 Cisplatin 22 Oxaliplatin 17 Carboplatin 17 Fluorouracil 13 Cytoreduction Surgical Procedures 13 Bevacizumab 10 Mitomycin 9 Leucovorin 8 Doxorubicin 8 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Neoadjuvant Therapy 3 Drug Therapy 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 epothilone B 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Peritoneal Neoplasms × alvimopan × Clear all

NCT03352414 2021-08-18

ILEUS

University of California, San Diego

Phase 2 Terminated

84 enrolled 10 charts

Peritoneal Neoplasms, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡